Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 21426103)

1.

Therapeutic potential of boron-containing compounds.

Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V, Xia Y.

Future Med Chem. 2009 Oct;1(7):1275-88. doi: 10.4155/fmc.09.71. Review.

2.

Nanomolar inhibitors of AmpC beta-lactamase.

Morandi F, Caselli E, Morandi S, Focia PJ, Blázquez J, Shoichet BK, Prati F.

J Am Chem Soc. 2003 Jan 22;125(3):685-95.

PMID:
12526668
3.

Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.

Hernandez V, Crépin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L, Meewan M, Mohan M, Mao W, Rock FL, Sexton H, Sheoran A, Zhang Y, Zhang YK, Zhou Y, Nieman JA, Anugula MR, Keramane el M, Savariraj K, Reddy DS, Sharma R, Subedi R, Singh R, O'Leary A, Simon NL, De Marsh PL, Mushtaq S, Warner M, Livermore DM, Alley MR, Plattner JJ.

Antimicrob Agents Chemother. 2013 Mar;57(3):1394-403. doi: 10.1128/AAC.02058-12. Epub 2013 Jan 7.

4.

Boron-containing inhibitors of synthetases.

Baker SJ, Tomsho JW, Benkovic SJ.

Chem Soc Rev. 2011 Aug;40(8):4279-85. doi: 10.1039/c0cs00131g. Epub 2011 Feb 7. Review.

PMID:
21298158
5.

Boron chemicals in diagnosis and therapeutics.

Das BC, Thapa P, Karki R, Schinke C, Das S, Kambhampati S, Banerjee SK, Van Veldhuizen P, Verma A, Weiss LM, Evans T.

Future Med Chem. 2013 Apr;5(6):653-76. doi: 10.4155/fmc.13.38. Review.

6.

Boron therapeutics on the horizon.

Groziak MP.

Am J Ther. 2001 Sep-Oct;8(5):321-8. Review.

PMID:
11550073
7.

Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.

Weston GS, Blázquez J, Baquero F, Shoichet BK.

J Med Chem. 1998 Nov 5;41(23):4577-86.

PMID:
9804697
8.

Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors.

Touchet S, Carreaux F, Carboni B, Bouillon A, Boucher JL.

Chem Soc Rev. 2011 Jul;40(7):3895-914. doi: 10.1039/c0cs00154f. Epub 2011 Mar 22. Review.

PMID:
21431144
9.

Permeation through the cell membrane of a boron-based β-lactamase inhibitor.

Minozzi M, Lattanzi G, Benz R, Costi MP, Venturelli A, Carloni P.

PLoS One. 2011;6(8):e23187. doi: 10.1371/journal.pone.0023187. Epub 2011 Aug 17.

10.

Boronic acid compounds as potential pharmaceutical agents.

Yang W, Gao X, Wang B.

Med Res Rev. 2003 May;23(3):346-68. Review.

PMID:
12647314
11.

AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids.

Tafi A, Agamennone M, Tortorella P, Alcaro S, Gallina C, Botta M.

Eur J Med Chem. 2005 Nov;40(11):1134-42. Epub 2005 Sep 8.

PMID:
16153747
12.

Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors.

Mascaretti OA, Danelon GO, Laborde M, Mata EG, Setti EL.

Curr Pharm Des. 1999 Nov;5(11):939-53. Review.

PMID:
10539998
13.

[The history of the development and changes of quinolone antibacterial agents].

Takahashi H, Hayakawa I, Akimoto T.

Yakushigaku Zasshi. 2003;38(2):161-79. Japanese.

PMID:
15143768
14.

4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.

Tan Q, Ogawa AM, Painter RE, Park YW, Young K, DiNinno FP.

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2622-4. doi: 10.1016/j.bmcl.2010.02.065. Epub 2010 Feb 19.

PMID:
20299220
15.

Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases.

Poplawski SE, Lai JH, Sanford DG, Sudmeier JL, Wu W, Bachovchin WW.

J Med Chem. 2011 Apr 14;54(7):2022-8. doi: 10.1021/jm100972f. Epub 2011 Mar 9.

PMID:
21388136
17.

Recent advances in the medicinal chemistry of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives.

Dembitsky VM, Quntar AA, Srebnik M.

Mini Rev Med Chem. 2004 Nov;4(9):1001-18. Review.

PMID:
15544560
18.
19.

Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.

Thomson KS, Smith Moland E.

Microbes Infect. 2000 Aug;2(10):1225-35. Review.

PMID:
11008112
20.

Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents.

Ochsner UA, Sun X, Jarvis T, Critchley I, Janjic N.

Expert Opin Investig Drugs. 2007 May;16(5):573-93. Review.

PMID:
17461733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk